Herpes zoster infection, vaccination and immunocompromised rheumatology patients.
AffiliationDepartment of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland. email@example.com
MetadataShow full item record
CitationHerpes zoster infection, vaccination and immunocompromised rheumatology patients. 2013, 33 (1):239-40 Rheumatol. Int.
AbstractVaricella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.
- Herpes zoster and the search for an effective vaccine.
- Authors: Arnold N, Messaoudi I
- Issue date: 2017 Jan
- Varicella vaccination in the immunocompromised.
- Authors: Malaiya R, Patel S, Snowden N, Leventis P
- Issue date: 2015 Apr
- Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
- Authors: Leuvenink R, Aeschlimann F, Baer W, Berthet G, Cannizzaro E, Hofer M, Kaiser D, Schroeder S, Heininger U, Woerner A
- Issue date: 2016 Jun 2
- Varicella and herpes zoster vaccines: WHO position paper, June 2014.
- Issue date: 2014 Jun 20